Literature DB >> 2831856

Antibody activity to herpes simplex virus in mouse Ig classes and IgG subclasses.

R R McKendall1, W Woo.   

Abstract

Recent studies indicate that Ig class and IgG subclass induction varies for different proteins and further that some Ig subclasses, like IgG2a, are more efficient in important biologic processes such as antibody-dependant cell-mediated cytotoxicity (ADCC). Many proteins of herpes simplex virus type 1 (HSV-1) are immunogenic and induce immunoglobulin responses. To determine the distribution of immunoglobulins induced by HSV-1 proteins, we studied immune mouse serum using an Ig isotype specific Elisa assay for antiviral activity. We found by endpoint analysis that the antiviral titer was 1:12,903 for IgG1, 1:5141 for IgG2a, 1:2140 for IgG2b and 1:229 for IgG3. To identify which isotypes were induced by individual glycoproteins and other viral proteins, Western blots containing HSV-1 proteins were probed with immune serum and isotype specific second antibodies. gB, gC, gD and the 42/44KDa nucleocapsid complex induced strong IgG1, IgG2a, IgG2b responses. IgG3 reactivity with viral proteins appeared weaker. Among the IgG3 reactivities detected on immunoblots, gB and gC were the most intense. Other proteins which elicited IgG1, IgG2a and IgG2b responses were 170KDa, 154KDa and gE. IgA responses were induced by 154KDa, gC, gB, gE and gD. Prominent IgM responses included gB, gC, gD and the 42KDa protein. These results indicate that HSV-1 glycoproteins induce prominent responses in all IgG isotypes except IgG3. The biologic implications of the data are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831856     DOI: 10.1007/BF01322171

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  The polyspecific immunoglobulin response to HSV-1 viral proteins: determination of immunogenic proteins and relative antibody titres to individual polypeptides by immunoblotting.

Authors:  R R McKendall; M Pettit; W Woo
Journal:  J Med Microbiol       Date:  1988-01       Impact factor: 2.472

2.  Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.

Authors:  G Kümel; H C Kaerner; M Levine; C H Schröder; J C Glorioso
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

3.  Herpes virus latency in spinal ganglia of mice without illness.

Authors:  R R McKendall; N Vogelzang; G G Jackson
Journal:  Proc Soc Exp Biol Med       Date:  1974-09

4.  Immunologic control of a retrovirus-associated murine adenocarcinoma. VII. Tumor cell destruction by macrophages and IgG2A.

Authors:  A J Langlois; T J Matthews; K J Weinhold; D P Bolognesi
Journal:  J Natl Cancer Inst       Date:  1985-10       Impact factor: 13.506

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Activation of mouse complement by different classes of mouse antibody.

Authors:  G G Klaus; M B Pepys; K Kitajima; B A Askonas
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

7.  The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.

Authors:  R Eberle; S W Mou; J A Zaia
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

8.  Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.

Authors:  G E Mortimer; J P Widdowson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

9.  Antibody responses in humans to individual proteins of herpes simplex viruses.

Authors:  S C Gilman; J J Docherty; W E Rawls
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

10.  Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.

Authors:  D Herlyn; J Powe; A H Ross; M Herlyn; H Koprowski
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

View more
  3 in total

1.  Murine acute retinal necrosis.

Authors:  C S Foster; M Zierhut; H Wu; R Tamesis; N Jabbur
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Herpes simplex virus type 1 strain KOS-63 does not cause acute or recurrent ocular disease and does not reactivate ganglionic latency in vivo.

Authors:  W G Stroop; M C Banks
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

3.  Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.

Authors:  Michael T Hensel; Jason D Marshall; Michael R Dorwart; Darren S Heeke; Eileen Rao; Padmaja Tummala; Li Yu; Gary H Cohen; Roselyn J Eisenberg; Derek D Sloan
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.